Navigation Links
Martek to Announce First Quarter 2009 Results
Date:2/17/2009

COLUMBIA, Md., Feb. 17 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq: MATK) announced that it intends to release the results of its first quarter of fiscal 2009 on March 4, 2009, at approximately 4:00 p.m. Eastern Time (ET). Following the release, at 4:45 p.m. ET Martek will conduct a conference call to discuss these results with investors. All interested parties may listen to the call live via webcast by visiting Martek's web site at http://investors.martek.com.

An archived webcast of the conference call will be available on the Martek's website for thirty days. In addition, a recorded playback of the call will be available for one week and can be accessed by calling 800-633-8284 or 402-977-9140 and entering pass code 214 15 482.

Martek Biosciences Corporation is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The Company produces life'sDHA, a sustainable and vegetarian source of DHA omega-3, for use in foods, beverages, infant formula and supplements, and life'sARA (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit http://www.martek.com/.

    Contact:  Kyle Stults
              Investor Relations
              (410) 740-0081

              Cassie France-Kelly
              Public Relations
              (410) 740-0081


'/>"/>
SOURCE Martek Biosciences Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Marteks lifesDHA(TM) Featured in Four New Products from Spectrum Organics
2. Marteks lifesDHA(TM) Now Available in Rachels(TM) Yogurt at Grocery Retailers Nationwide
3. Martek to Present at Upcoming Needham Conference
4. Australias Leading Juice Company Launches Juice Blend with Marteks lifesDHA(TM)
5. Sunkist Naturals Glorious Greens Smoothie Features Marteks lifesDHA
6. Martek Announces First Quarter 2008 Financial Results
7. Marteks lifesDHA(TM) Featured in Three New Offerings of Baby Food from Plum Organics
8. Summary Notice of Proposed Settlement and Settlement Hearing in Re Martek Biosciences Corp., Securities Litigation
9. Pocket Rocket Juice from Australias Boost Juice Features 700 mg of Marteks lifesDHA(TM)
10. Martek Announces Settlement of Class Action Lawsuit
11. Marteks lifesDHA(TM) Featured in Dalco Foods Wellness Line Meat Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... Richard Strawn’s new book ... time of a cancer diagnosis, surgery and recovery, the Psalms provided encouragement and ... ways God shows love to those who are sick., Surgical Psalms contains 36 ...
(Date:8/16/2017)... ... 16, 2017 , ... The Visiting Nurse Association (VNA) ... train as hospice volunteers. Volunteers provide much needed joy, support and assistance to ... agency has trained volunteers to be vital members of the interdisciplinary hospice care ...
(Date:8/16/2017)... ... , ... Rollon Skin Care Ltd., one of ... the launch of two new skincare products, Prache Antiaging Cream and Prache Antiaging ... surgery or in-patient cosmetic dermatological procedures. , “Prache Antiaging Cream and Prache Antiaging ...
(Date:8/16/2017)... ... ... “Faith, Through The Eyes of A Child” is the creation of published author, Pauline DiBenedetto. ... at her. Since she was in such great pain, my mother thought that her time ... well. It wasn’t until I was about eight years old, when I had a vision ...
(Date:8/15/2017)... ... August 15, 2017 , ... The first study to ... multiple myeloma has been completed, with the team’s findings now published online ahead of ... , Director of the Blood and Marrow Transplant Program at Roswell Park Cancer Institute, ...
Breaking Medicine News(10 mins):
(Date:8/11/2017)... , Aug. 11, 2017 DarioHealth Corp. (NASDAQ: ... health and big data solutions, today announced that it ... August 14 and host a conference call at 9:00am ... operating and financial results and its strategy and outlook ... hosted by Erez Raphael , Chief Executive Officer, ...
(Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
(Date:8/7/2017)... , Aug. 7, 2017 Insightin Health, ... acquisition, retention, and engagement, announced the selection of ... and Product Development, effective as of February 2017. In ... technology implementation strategy for our clients. Wood brings ... in consulting and business analytics within the healthcare ...
Breaking Medicine Technology: